Company Profile

Lumigen Inc
Profile last edited on: 4/23/19      CAGE: 47M05      UEI:

Business Identifier: Chemiluminescent detection technologies
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

22900 West Eight Mile Road
Southfield, MI 48034
   (248) 351-5600
Location: Single
Congr. District: 14
County: Oakland

Public Profile

In March 2006, Lumigen Inc was acquired by Beckman Coulter, Inc. Lumigen, Inc., had supplied chemiluminescent reagents to the clinical immunodiagnostics market. The firm had been involved in the research, development, manufacture and market novel chemiluminescent compounds for use in life science research and medical diagnostics. With their chemiluminescent reagents are now used worldwide in automated systems for the chemiluminescent detection of alkaline phosphatase conjugates and in ultrasensitive assays in the fields of life science research and human identity testing.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2007 2 NIH $831,412
Project Title: Materials for Isolation of Nucleic Acids from Whole Blood without a Lysis Step
2004 2 NIH $833,606
Project Title: Molecular Diagnostic Assays for Genetic Disease
2002 1 NIH $100,000
Project Title: Chemiluminescent Labeling and Detection in Gels
1998 1 NIH $75,017
Project Title: Multiplex Chemiluminescent DNA Sequencing
1997 1 NIH $100,000
Project Title: Novel Chemiluminescent Detection Of Gene Rearrangements

Key People / Management

  A Paul Schaap -- President

  Hashem Akhavan-Tafti -- Vice President

  Carolyn Grabarczyk

  Richard Handley

Company News

There are no news available.